Imagine this: You’re on a tropical getaway…but between the persistent vaginal itching and irritation you’re feeling, you’re in sweatpants instead of a bikini. Recurrent bacterial vaginosis doesn’t ...

-- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with ...

Bacterial vaginosis (BV) is a relatively common vaginal condition in women between 15 and 44 years. This bacterial infection manifests recurrently despite antibiotic treatment. There are not many ...

In a recent study published in the Cell, a group of researchers investigated oleic acid (OA) as a potential treatment to inhibit Lactobacillus iners (L. iners) and promote Lactobacillus crispatus (L.

Microbes are important in the gut, skin, mouth — and in the vagina. Postdoctoral research scientist Fatima Aysha Hussain says that unlike our gut, a healthy vaginal microbiome is likely one with a low ...

Women with bacterial vaginosis, a recurrent condition that raises the risk of pregnancy complications, could benefit from ...

One in three women are affected by bacterial vaginosis (BV), a common but poorly understood condition caused by an imbalance of vaginal bacteria that can cause discomfort and pain. BV is treated with ...

Are you feeling less-than-great down there lately? Unpleasant symptoms like itching, burning and discharge are typical of two very common conditions: bacterial vaginosis and yeast infections. If ...

All products featured on Self are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Read on to learn how ...

Share on Pinterest Bacterial vaginosis (BV) is not classified as a sexually transmitted infection, but the results of a new study could change that. ljubaphoto/Getty Images New research suggests a ...

SAN DIEGO, June 11, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent ...